Pediatrics in Review Note to Institutions for Site Subscriptions
HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Rapid Responses: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Rapid Responses are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murphy, S. J.
Right arrow Articles by Kelly, H. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murphy, S. J.
Right arrow Articles by Kelly, H. W.

Advances in the Management of Acute Asthma in Children

Shirley J. Murphy MD1
H. William Kelly PharmD2
 1 Professor and Chair, Department of Pediatrics. (Dr Murphy is a Consultant to Fisons Corporation and Astra Pharmaceuticals.)
2 Professor of Pharmacy and Pediatrics, University of New Mexico, Albuquerque. (Dr Kelly is a Glaxo stockholder.)

In 1991, the National Heart, Lung and Blood Institute's National Asthma Education Program (NAEP) published "Guidelines for the Diagnosis and Management of Asthma" recommended by an expert panel. This was followed in 1992 by the publication of the "Internal Consensus Report on Diagnosis and Management of Asthma" (ICR). These reports reviewed the current state of knowledge and established the goals of therapy for both chronic asthma and acute exacerbations. This article will provide an update on the research that has been published since those recommendations.

The first NAEP guidelines established three goals for the treatment of acute asthma: Rapid reversal of airflow obstruction, correction of significant hypoxemia, and reduction of the rate of recurrent severe asthma symptoms. The ICR added two additional goals: Restoration of lung function to normal as soon as possible and development of a written plan of action in case of a further exacerbation.

Both reports concluded that these goals could be accomplished best by aggressive use of inhaled selective beta2-agonists and early introduction of systemic corticosteroids (in certain patients at home). The liberal use of low-flow oxygen was considered safe; it often easily corrects the hypoxemia produced by the alveolar hypoventilation and the mismatch in ventilation/perfusion (V/Q) that frequently accompanies acute asthma exacerbations.




This article has been cited by other articles:


Home page
 PediatricsHome page
G. Rachelefsky
Treating Exacerbations of Asthma in Children: The Role of Systemic Corticosteroids
Pediatrics, August 1, 2003; 112(2): 382 - 397.
[Abstract] [Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
S. Guendelman, K. Meade, M. Benson, Y. Q. Chen, and S. Samuels
Improving Asthma Outcomes and Self-management Behaviors of Inner-city Children: A Randomized Trial of the Health Buddy Interactive Device and an Asthma Diary
Arch Pediatr Adolesc Med, February 1, 2002; 156(2): 114 - 120.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
M. J. Russo, K. M. McConnochie, J. T. McBride, P. G. Szilagyi, A. M. Brooks, and K. J. Roghmann
Increase in Admission Threshold Explains Stable Asthma Hospitalization Rates
Pediatrics, September 1, 1999; 104(3): 454 - 462.
[Abstract] [Full Text] [PDF]


HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
Pediatrics Pediatrics in Review
Copyright © 1996 by the American Academy of Pediatrics.